Literature DB >> 17868963

What do we (need to) know about the kinetic properties of nanoparticles in the body?

Werner I Hagens1, Agnes G Oomen, Wim H de Jong, Flemming R Cassee, Adriënne J A M Sips.   

Abstract

Nowadays the development and applications of nanotechnology are of major importance in both industrial and consumer areas. However, the knowledge on human exposure and possible toxicity of nanotechnology products is limited. To understand the mechanism of toxicity, thorough knowledge of the toxicokinetic properties of nanoparticles is warranted. There is a need for information on the absorption, distribution, metabolism and excretion (ADME) of nanoparticles and validated detection methods of these man-made nanoparticles. Determination of the ADME properties of nanoparticles requires specialised detection methods in different biological matrices (e.g. blood and organs). In this paper, the current knowledge on the kinetic properties of nanoparticles is reviewed. Moreover, knowledge gaps from a kinetic point of view (detection, dose, ADME processes) are identified.

Entities:  

Mesh:

Year:  2007        PMID: 17868963     DOI: 10.1016/j.yrtph.2007.07.006

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  53 in total

Review 1.  Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Authors:  Sonu Bhaskar; Furong Tian; Tobias Stoeger; Wolfgang Kreyling; Jesús M de la Fuente; Valeria Grazú; Paul Borm; Giovani Estrada; Vasilis Ntziachristos; Daniel Razansky
Journal:  Part Fibre Toxicol       Date:  2010-03-03       Impact factor: 9.400

2.  Changes in silica nanoparticles upon internalisation by cells: size, aggregation/agglomeration state, mass- and number-based concentrations.

Authors:  Dorota Bartczak; Julie Davies; Christian Gollwitzer; Michael Krumrey; Heidi Goenaga-Infante
Journal:  Toxicol Res (Camb)       Date:  2018-01-23       Impact factor: 3.524

Review 3.  Progress of in vivo studies on the systemic toxicities induced by titanium dioxide nanoparticles.

Authors:  Fashui Hong; Xiaohong Yu; Nan Wu; Yu-Qing Zhang
Journal:  Toxicol Res (Camb)       Date:  2017-01-04       Impact factor: 3.524

4.  Polymeric Nanoparticles Controlled by On-Chip Self-Assembly Enhance Cancer Treatment Effectiveness.

Authors:  Sungjin Jung; Junseok Lee; Junha Lim; Jeeyeon Suh; Taeyoung Kim; Jungho Ahn; Won Jong Kim; YongTae Kim
Journal:  Adv Healthc Mater       Date:  2020-10-18       Impact factor: 9.933

Review 5.  Are clinical findings of systemic titanium dispersion following implantation explained by available in vitro evidence? An evidence-based analysis.

Authors:  Justin Paul Curtin; Minji Wang
Journal:  J Biol Inorg Chem       Date:  2017-05-17       Impact factor: 3.358

6.  Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.

Authors:  Sara M Navarro; Caleb Darensbourg; Linda Cross; Rhett Stout; Diana Coulon; Carlos E Astete; Timothy Morgan; Cristina M Sabliov
Journal:  Ther Deliv       Date:  2014-11

7.  Urban air pollution: influences on olfactory function and pathology in exposed children and young adults.

Authors:  Lilian Calderón-Garcidueñas; Maricela Franco-Lira; Carlos Henríquez-Roldán; Norma Osnaya; Angelica González-Maciel; Rafael Reynoso-Robles; Rafael Villarreal-Calderon; Lou Herritt; Diane Brooks; Sheyla Keefe; Juan Palacios-Moreno; Rodolfo Villarreal-Calderon; Ricardo Torres-Jardón; Humberto Medina-Cortina; Ricardo Delgado-Chávez; Mario Aiello-Mora; Robert R Maronpot; Richard L Doty
Journal:  Exp Toxicol Pathol       Date:  2009-03-17

Review 8.  Titanium dioxide nanoparticles: a review of current toxicological data.

Authors:  Hongbo Shi; Ruth Magaye; Vincent Castranova; Jinshun Zhao
Journal:  Part Fibre Toxicol       Date:  2013-04-15       Impact factor: 9.400

Review 9.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2008-10       Impact factor: 5.307

10.  On the toxicity of therapeutically used nanoparticles: an overview.

Authors:  A El-Ansary; S Al-Daihan
Journal:  J Toxicol       Date:  2009-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.